US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
GlobalData on MSN17h
ViiV Healthcare and J&J’s adolescent HIV-1 combo gains EC authorisationThe European Commission (EC) has authorised the use of ViiV Healthcare’s Vocabria (cabotegravir long-acting injections) plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback